Delayed drug hypersensitivity: models of T-cell stimulation - Wikidata - wikimedia - TriplyDB

Delayed drug hypersensitivity: models of T-cell stimulation

Delayed drug hypersensitivity: models of T-cell stimulation

http://www.wikidata.org/entity/Q34976476

about

Toxic epidermal necrolysis T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity Idiosyncratic adverse drug reactions: current concepts Immediate-type hypersensitivity drug reactions Drug allergy: causes and desensitization Pharmacogenomics of adverse drug reactions Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses Relationships Between Pharmacovigilance, Molecular, Structural, and Pathway Data: Revealing Mechanisms for Immune-Mediated Drug-Induced Liver Injury.The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review Antiviral drug allergy.Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide.Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.Inmunohistochemical detection of mastocytes in tissue from patients with actinic prurigo Correlation of serum IgE levels and clinical manifestations in patients with actinic prurigo HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.Genetic association studies in drug-induced liver injury.Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.Acute interstitial nephritis - a reappraisal and update.Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.Allopurinol induces innate immune responses through mitogen-activated protein kinase signaling pathways in HL-60 cells.Skin sensitizers in cosmetics and beyond: potential multiple mechanisms of action and importance of T-cell assays for in vitro screening.HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.Recent progress of elucidating the mechanisms of drug hypersensitivity.Avidity determines T-cell reactivity in abacavir hypersensitivity.Allergy, pseudo-allergy and non-allergy.Rash, organ dysfunction, and eosinophiles: it is a DRESS.Systemic delayed hypersensitivity reaction to chlorambucil: a case report and literature review.Inhibitory Effects of the Standardized Extract of Phyllanthus amarus on Cellular and Humoral Immune Responses in Balb/C Mice.Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity.Pyogranulomatous mural folliculitis in a cat treated with methimazole.A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02

P2860

Q26745232-38398594-C2F1-4CAD-BD28-C08FAE9E8C72 Q26747638-1DE7385A-4830-42D7-8F38-58DFC710329D Q26784638-2C3FA329-DE31-4307-B42E-42556C78C2CD Q26800964-940BA1C1-8850-4DBC-9C7E-D5974DB377F4 Q26800976-FA5D2934-3BAF-4443-B5ED-4BD1739F7D12 Q26824391-1694FD8A-CE58-4980-BD3B-28003F114441 Q26995860-B9E0BF6B-61DC-4E34-8E1E-B673B791B4F0 Q27012238-8FDA7680-2763-4277-8A39-FBE4A64F08D6 Q27015820-15C6CE2A-33F3-4FAA-A1CA-8F04FBAB4030 Q28477582-0E4ADEAC-BE39-4C75-AAE4-BDB1A3CB844C Q28538078-7698156E-0F3D-4E1A-91C4-4572FB7AD231 Q30990061-33DEC53A-DC0F-4762-AA41-B9120C103760 Q34016198-5FEA3FAC-F0F7-4991-AF20-7B789E75B031 Q34075812-3A6F1A0C-3199-4CB3-9317-4F0D60AF4E26 Q34140322-972995D8-DDD6-4EC8-B73A-07143FAA6435 Q34540731-2B04D99F-2C8C-45DD-8C4D-C5B1381D253C Q35657599-E6D4058A-7402-4BA7-AEE9-20253F4A008D Q36029478-01785556-612B-4A8B-8870-E0B0FA58B4FB Q36328185-E3A2C061-67A3-434A-B759-DBB139EBE72C Q36663187-7647F12C-BC97-4164-A899-5EAAF793E3B6 Q37100410-DD4A00F2-8093-427A-BE63-E875EDF4B65D Q37931275-790D42C1-E575-45DF-995D-17B1980FE082 Q38003494-413D3067-1C2F-4FC8-90AD-C823DE693CD4 Q38235631-B0549B74-E9BF-46CE-A88F-4F2857FA16FF Q38360770-FABAEEEB-9646-4A21-A9BF-C465842C7846 Q38814020-661F0B40-8C11-448F-A239-DAF263201261 Q38888014-E14F575E-C1FF-49CE-9E0A-CA69D0983772 Q38949927-B83829DE-E771-44A4-8D63-14B8FB56D499 Q41827577-C73E2552-1B0F-4FC1-A543-7F72C492763C Q42718095-F4C851FE-595D-4BC5-BE0E-42297948909B Q42732383-F5DCF0A4-DF80-4163-8A75-A7025B2C2DD0 Q44984976-227553B6-226A-4857-90E4-7ED27703DAF3 Q48229242-5A7C7610-2527-4800-BE8D-7503C1DF2594 Q50241908-55E084DB-2B82-41E9-8997-2BE1236D0493 Q50624617-13C05F63-BC56-4117-B986-87912B226ECE Q51196197-CD50B7BF-AC11-4EBA-B8C2-5E672935AF62 Q51297747-F89C2720-5248-49CE-A805-E9882A58194A Q55077637-22462D4A-D5DE-4C92-B6D1-E92DC2367B65 Q57300409-9837AFD9-F301-4820-9DE1-1E3383C508FD

P2860

Delayed drug hypersensitivity: models of T-cell stimulation

http://www.wikidata.org/entity/Q34976476

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Delayed drug hypersensitivity: models of T-cell stimulation

@ast

Delayed drug hypersensitivity: models of T-cell stimulation

@en

Delayed drug hypersensitivity: models of T-cell stimulation

@nl

type

label

Delayed drug hypersensitivity: models of T-cell stimulation

@ast

Delayed drug hypersensitivity: models of T-cell stimulation

@en

Delayed drug hypersensitivity: models of T-cell stimulation

@nl

prefLabel

Delayed drug hypersensitivity: models of T-cell stimulation

@ast

Delayed drug hypersensitivity: models of T-cell stimulation

@en

Delayed drug hypersensitivity: models of T-cell stimulation

@nl

P1433

Q34976476-FED5FFB7-4315-4E07-AD6B-FAA84781AD07

P1476

Q34976476-168A0C27-1FE8-479E-90F9-B4E1891CF1A2

P2093

Q34976476-4DEB999E-C3E3-46C5-B703-A5A9D51493AA

Q34976476-94265370-D4EF-4D89-8DB9-B534A5B10AD2

Q34976476-DE461D47-2E2B-48D0-83AB-E68AE3E6B52E

P2860

Q34976476-0C5F8277-A1F4-4C6C-95BD-9D3C31CB9012

Q34976476-1B1D0D96-C580-4501-8AE6-681B5E962E01

Q34976476-227C3C56-4D70-4C0C-A35C-FFD3A47B100C

Q34976476-25D8DE44-1790-4B67-801B-964E7BA0F2EB

Q34976476-261F79B6-07FF-4512-9BD6-5265034A7A73

Q34976476-3A58951F-D2FF-4E76-943F-2CA0152BD34E

Q34976476-3AFA7D68-80AB-4292-A056-16F0D6047568

Q34976476-3E72BEC2-4B43-48A9-831B-2C01C6805308

Q34976476-422571DD-449E-4226-9B31-B29459568309

Q34976476-4A609654-91A6-4719-8783-D49CB774DB7A

P304

Q34976476-607DAE6F-91EC-4AF7-9D9E-4B10B6AAB4F7

P31

Q34976476-80142334-B1B1-4EE5-A8FF-5FC329C7D003

P356

Q34976476-6DCCC186-8F64-4537-A8E0-E9F2983FD4B5

P407

Q34976476-72FF7ABF-4DDE-4C38-9EC2-560799535FEB

P433

Q34976476-22864F95-9287-463E-8E3F-A5BFC82159A8

P478

Q34976476-BD788852-2ED2-49A6-ABB2-42AA50026893

P577

Q34976476-FFE9856E-EB6A-46DA-B86F-4B76D056B3F2

P5875

Q34976476-1DFB703C-5463-4A47-8E12-7BA7E391B8B5

P698

Q34976476-0204BAC2-0F27-411A-8716-DDF18CA97E26

P932

Q34976476-88908951-8471-45BF-82F8-4C149A639DD2

P356

J.1365-2125.2010.03764.X

P1433

British Journal of Clinical Pharmacology

P1476

Delayed drug hypersensitivity: models of T-cell stimulation

@en

P2093

Daniel Yerly

http://www.w3.org/2001/XMLSchema#string

Jacqueline Adam

http://www.w3.org/2001/XMLSchema#string

Werner J Pichler

http://www.w3.org/2001/XMLSchema#string

P2860

Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population

T-cell involvement in drug-induced acute generalized exanthematous pustulosis

Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

P304

701-707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2010.03764.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51039825

http://www.w3.org/2001/XMLSchema#string

P698

21480949

http://www.w3.org/2001/XMLSchema#string

P932

3093075

http://www.w3.org/2001/XMLSchema#string